Get the Stockscreener App
0.8086
2.19%
0.0173
After Hours:
.82
0.0114
+1.41%
iBio Inc stock is traded at $0.8086, with a volume of 254.43K.
It is up +2.19% in the last 24 hours and down -13.38% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.7913
Open:
$0.7913
24h Volume:
254.43K
Relative Volume:
0.32
Market Cap:
$15.89M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1219
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
-4.85%
1M Performance:
-13.38%
6M Performance:
-32.62%
1Y Performance:
-69.25%
1-Day Range:
$0.791
$0.8237
1-Week Range:
$0.7811
$0.89
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.8086 | 16.03M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
iBio Inc Stock (IBIO) Latest News
Why iBio Inc. stock is rated strong buyJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
How to manage a losing position in iBio Inc.2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Can iBio Inc. stock double in next 5 years2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com
Head to Head Survey: iBio (IBIO) & The Competition - Defense World
Tick level data insight on iBio Inc. volatilityJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
Applying Wyckoff theory to iBio Inc. stock2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
How to read the order book for iBio Inc.Portfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Why iBio Inc. (0JV0) stock could be next leaderEarnings Overview Summary & AI Driven Price Predictions - newser.com
Is iBio Inc. stock ready for a breakout2025 Institutional Moves & Community Consensus Picks - newser.com
Head-To-Head Contrast: iBio (IBIO) & Its Peers - Defense World
Is iBio Inc. (0JV0) stock worth holding before Fed meetingWeekly Trade Review & AI Forecast Swing Trade Picks - newser.com
Using data models to predict iBio Inc. stock movementEarnings Risk Report & AI Driven Stock Reports - newser.com
Is iBio Inc. (0JV0) stock a contrarian opportunityPortfolio Value Summary & Long-Term Growth Plans - newser.com
What analysts say about iBio Inc stockFibonacci Extensions & Free Stock Market Mentorship Programs - earlytimes.in
Real time alert setup for iBio Inc. performance2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
iBio Inc Stock Analysis and ForecastGlobal Trade Effects & Free ETF and Mutual Fund Comparisons - earlytimes.in
Using Ichimoku Cloud for iBio Inc. technicalsEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Detecting support and resistance levels for iBio Inc.2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Is iBio Inc 0JV0 a good long term investmentMid Cap Growth Trends & High Profit Portfolio Growth - earlytimes.in
What drives iBio Inc stock priceSector Rotation Strategies & Low Cost Wealth Strategies - earlytimes.in
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):